Cargando…

Incidence of post myocardial infarction left ventricular thrombus formation in the era of primary percutaneous intervention and glycoprotein IIb/IIIa inhibitors. A prospective observational study

BACKGROUND: Before the widespread use of primary percutaneous coronary intervention (PCI) and glycoprotein IIb/IIIa inhibitors (GP IIb/IIIa) left ventricular (LV) thrombus formation had been reported to complicate up to 20% of acute myocardial infarctions (AMI). The incidence of LV thrombus formatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Rehan, Arshad, Kanwar, Manpreet, Rosman, Howard, Ahmed, Sujood, Ali, Arshad, Gardin, Julius, Cohen, Gerald
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1458359/
https://www.ncbi.nlm.nih.gov/pubmed/16600036
http://dx.doi.org/10.1186/1476-7120-4-20
_version_ 1782127437593706496
author Rehan, Arshad
Kanwar, Manpreet
Rosman, Howard
Ahmed, Sujood
Ali, Arshad
Gardin, Julius
Cohen, Gerald
author_facet Rehan, Arshad
Kanwar, Manpreet
Rosman, Howard
Ahmed, Sujood
Ali, Arshad
Gardin, Julius
Cohen, Gerald
author_sort Rehan, Arshad
collection PubMed
description BACKGROUND: Before the widespread use of primary percutaneous coronary intervention (PCI) and glycoprotein IIb/IIIa inhibitors (GP IIb/IIIa) left ventricular (LV) thrombus formation had been reported to complicate up to 20% of acute myocardial infarctions (AMI). The incidence of LV thrombus formation with these treatment modalities is not well known. METHODS: 92 consecutive patients with ST-elevation AMI treated with PCI and GP IIb/IIIa inhibitors underwent 2-D echocardiograms, with and without echo contrast agent, within 24–72 hours. RESULTS: Only 4/92 (4.3%) had an LV thrombus, representing a significantly lower incidence than that reported in the pre-PCI era. Use of contrast agents did not improve detection of LV thrombi in our study. CONCLUSION: The incidence of LV thrombus formation after acute MI, in the current era of rapid reperfusion, is lower than what has been historically reported.
format Text
id pubmed-1458359
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-14583592006-05-06 Incidence of post myocardial infarction left ventricular thrombus formation in the era of primary percutaneous intervention and glycoprotein IIb/IIIa inhibitors. A prospective observational study Rehan, Arshad Kanwar, Manpreet Rosman, Howard Ahmed, Sujood Ali, Arshad Gardin, Julius Cohen, Gerald Cardiovasc Ultrasound Research BACKGROUND: Before the widespread use of primary percutaneous coronary intervention (PCI) and glycoprotein IIb/IIIa inhibitors (GP IIb/IIIa) left ventricular (LV) thrombus formation had been reported to complicate up to 20% of acute myocardial infarctions (AMI). The incidence of LV thrombus formation with these treatment modalities is not well known. METHODS: 92 consecutive patients with ST-elevation AMI treated with PCI and GP IIb/IIIa inhibitors underwent 2-D echocardiograms, with and without echo contrast agent, within 24–72 hours. RESULTS: Only 4/92 (4.3%) had an LV thrombus, representing a significantly lower incidence than that reported in the pre-PCI era. Use of contrast agents did not improve detection of LV thrombi in our study. CONCLUSION: The incidence of LV thrombus formation after acute MI, in the current era of rapid reperfusion, is lower than what has been historically reported. BioMed Central 2006-04-06 /pmc/articles/PMC1458359/ /pubmed/16600036 http://dx.doi.org/10.1186/1476-7120-4-20 Text en Copyright © 2006 Rehan et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Rehan, Arshad
Kanwar, Manpreet
Rosman, Howard
Ahmed, Sujood
Ali, Arshad
Gardin, Julius
Cohen, Gerald
Incidence of post myocardial infarction left ventricular thrombus formation in the era of primary percutaneous intervention and glycoprotein IIb/IIIa inhibitors. A prospective observational study
title Incidence of post myocardial infarction left ventricular thrombus formation in the era of primary percutaneous intervention and glycoprotein IIb/IIIa inhibitors. A prospective observational study
title_full Incidence of post myocardial infarction left ventricular thrombus formation in the era of primary percutaneous intervention and glycoprotein IIb/IIIa inhibitors. A prospective observational study
title_fullStr Incidence of post myocardial infarction left ventricular thrombus formation in the era of primary percutaneous intervention and glycoprotein IIb/IIIa inhibitors. A prospective observational study
title_full_unstemmed Incidence of post myocardial infarction left ventricular thrombus formation in the era of primary percutaneous intervention and glycoprotein IIb/IIIa inhibitors. A prospective observational study
title_short Incidence of post myocardial infarction left ventricular thrombus formation in the era of primary percutaneous intervention and glycoprotein IIb/IIIa inhibitors. A prospective observational study
title_sort incidence of post myocardial infarction left ventricular thrombus formation in the era of primary percutaneous intervention and glycoprotein iib/iiia inhibitors. a prospective observational study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1458359/
https://www.ncbi.nlm.nih.gov/pubmed/16600036
http://dx.doi.org/10.1186/1476-7120-4-20
work_keys_str_mv AT rehanarshad incidenceofpostmyocardialinfarctionleftventricularthrombusformationintheeraofprimarypercutaneousinterventionandglycoproteiniibiiiainhibitorsaprospectiveobservationalstudy
AT kanwarmanpreet incidenceofpostmyocardialinfarctionleftventricularthrombusformationintheeraofprimarypercutaneousinterventionandglycoproteiniibiiiainhibitorsaprospectiveobservationalstudy
AT rosmanhoward incidenceofpostmyocardialinfarctionleftventricularthrombusformationintheeraofprimarypercutaneousinterventionandglycoproteiniibiiiainhibitorsaprospectiveobservationalstudy
AT ahmedsujood incidenceofpostmyocardialinfarctionleftventricularthrombusformationintheeraofprimarypercutaneousinterventionandglycoproteiniibiiiainhibitorsaprospectiveobservationalstudy
AT aliarshad incidenceofpostmyocardialinfarctionleftventricularthrombusformationintheeraofprimarypercutaneousinterventionandglycoproteiniibiiiainhibitorsaprospectiveobservationalstudy
AT gardinjulius incidenceofpostmyocardialinfarctionleftventricularthrombusformationintheeraofprimarypercutaneousinterventionandglycoproteiniibiiiainhibitorsaprospectiveobservationalstudy
AT cohengerald incidenceofpostmyocardialinfarctionleftventricularthrombusformationintheeraofprimarypercutaneousinterventionandglycoproteiniibiiiainhibitorsaprospectiveobservationalstudy